help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mason, D. R.
Right arrow Articles by Catt, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mason, D. R.
Right arrow Articles by Catt, K. J.

Endocrinology, Vol 135, 1165-1170, Copyright © 1994 by Endocrine Society


ARTICLES

Homologous down-regulation of gonadotropin-releasing hormone receptor sites and messenger ribonucleic acid transcripts in alpha T3-1 cells

DR Mason, KK Arora, LM Mertz and KJ Catt
Endocrinology and Reproduction Research Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.

GnRH is known to down-regulate its pituitary receptors by mechanisms that include endocytosis of the agonist-receptor complex. To evaluate the extent to which changes in receptor synthesis contribute to this process, the effects of GnRH and its analogs on GnRH receptor number and messenger RNA (mRNA) levels were analyzed in the alpha T3-1 gonadotroph cell line. Treatment with GnRH or its potent agonist analog, des-Gly10-[D-Ala6]GnRH N-ethylamide, reduced GnRH receptor number in a time- and dose-dependent manner, with a half-maximal decrease in response to 10(-6) M GnRH or agonist analog by 75 min. The maximum decrease in receptor number (to 31% of the control value) was sustained for up to 72 h. In alpha T3-1 cells incubated with 10(-8) M GnRH or agonist analog, the GnRH receptors fell by 28% and 46% after 2 h, respectively; no change in receptors occurred after treatment with 10(-8) M GnRH antagonist ([D-pGlu1,D-Phe2,D-Trp3,6]GnRH). Time- and dose-dependent reductions in the level of receptor mRNA were also observed after treatment of alpha T3-1 cells with GnRH and the agonist analog. However, the maximal reduction in mRNA levels (to 60-70% of the control value) was consistently less than the decline in receptor number. These results indicate that the mechanism of GnRH receptor down- regulation in alpha T3-1 gonadotrophs includes reduction of receptor synthesis secondary to decreases in receptor mRNA levels. The finding that reductions in mRNA levels were relatively less than the decreases in receptor number is consistent with the involvement of additional mechanisms, including endocytosis and degradation, in down-regulation of the GnRH receptor.


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
T. Cogliati, P. Delgado-Romero, E. R. Norwitz, J. Guduric-Fuchs, U. B. Kaiser, S. Wray, and I. R. Kirsch
Pubertal Impairment in Nhlh2 Null Mice Is Associated with Hypothalamic and Pituitary Deficiencies
Mol. Endocrinol., December 1, 2007; 21(12): 3013 - 3027.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
T Zhang and M S Roberson
Role of MAP kinase phosphatases in GnRH-dependent activation of MAP kinases
J. Mol. Endocrinol., February 1, 2006; 36(1): 41 - 50.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Liu, D. A. Austin, and N. J. G. Webster
Gonadotropin-Releasing Hormone-Desensitized L{beta}T2 Gonadotrope Cells Are Refractory to Acute Protein Kinase C, Cyclic AMP, and Calcium-Dependent Signaling
Endocrinology, October 1, 2003; 144(10): 4354 - 4365.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
B. Junoy, H. Maccario, J.-L. Mas, A. Enjalbert, and S. V. Drouva
Proteasome Implication in Phorbol Ester- and GnRH-Induced Selective Down-Regulation of PKC ({alpha}, {epsilon}, {zeta}) in {alpha}T3-1 and L{beta}T2 Gonadotrope Cell Lines
Endocrinology, April 1, 2002; 143(4): 1386 - 1403.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Wells, J. C. S. Souto, J. Solava, J. Kassis, K. J. Bailey, and T. Turner
Luteinizing Hormone-releasing Hormone Agonist Limits DU-145 Prostate Cancer Growth by Attenuating Epidermal Growth Factor Receptor Signaling
Clin. Cancer Res., April 1, 2002; 8(4): 1251 - 1257.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Halmos and A. V. Schally
Changes in subcellular distribution of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) after treatment with the LH-RH antagonist cetrorelix
PNAS, January 22, 2002; 99(2): 961 - 965.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Kovacs and A. V. Schally
Comparison of mechanisms of action of luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix and LHRH agonist triptorelin on the gene expression of pituitary LHRH receptors in rats
PNAS, October 9, 2001; 98(21): 12197 - 12202.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Kovacs, A. V. Schally, B. Csernus, and Z. Rekasi
Luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix down-regulates the mRNA expression of pituitary receptors for LH-RH by counteracting the stimulatory effect of endogenous LH-RH
PNAS, January 24, 2001; (2001) 31582398.
[Abstract] [Full Text]


Home page
Mol Hum ReprodHome page
S. Wolfahrt, B. Kleine, H. Jarry, and W. G. Rossmanith
Endogenous regulation of the GnRH receptor by GnRH in the human placenta
Mol. Hum. Reprod., January 1, 2001; 7(1): 89 - 95.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. W. Cheng, E. S. W. Ngan, S. K. Kang, B. K. C. Chow, and P. C. K. Leung
Transcriptional Down-Regulation of Human Gonadotropin-Releasing Hormone (GnRH) Receptor Gene by GnRH: Role of Protein Kinase C and Activating Protein 1
Endocrinology, October 1, 2000; 141(10): 3611 - 3622.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. W. Cheng, P. S. Nathwani, and P. C. K. Leung
Regulation of Human Gonadotropin-Releasing Hormone Receptor Gene Expression in Placental Cells
Endocrinology, July 1, 2000; 141(7): 2340 - 2349.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. S. Nathwani, S. K. Kang, K. W. Cheng, K.-C. Choi, and P. C. K. Leung
Regulation of Gonadotropin-Releasing Hormone and Its Receptor Gene Expression by 17{beta}-Estradiol in Cultured Human Granulosa-Luteal Cells
Endocrinology, May 1, 2000; 141(5): 1754 - 1763.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. Baratti-Elbaz, N. Ghinea, O. Lahuna, H. Loosfelt, C. Pichon, and E. Milgrom
Internalization and Recycling Pathways of the Thyrotropin Receptor
Mol. Endocrinol., October 1, 1999; 13(10): 1751 - 1765.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
G. Maya-Núñez and P. M. Conn
Transcriptional Regulation of the Gonadotropin-Releasing Hormone Receptor Gene Is Mediated in Part by a Putative Repressor Element and by the Cyclic Adenosine 3',5'-Monophosphate Response Element
Endocrinology, August 1, 1999; 140(8): 3452 - 3458.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
K. K. Arora, H.-O. Chung, and K. J. Catt
Influence of a Species-Specific Extracellular Amino Acid on Expression and Function of the Human Gonadotropin-Releasing Hormone Receptor
Mol. Endocrinol., June 1, 1999; 13(6): 890 - 896.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
H.-F. Chen, E.-B. Jeung, M. Stephenson, and P. C. K. Leung
Human Peripheral Blood Mononuclear Cells Express Gonadotropin-Releasing Hormone (GnRH), GnRH Receptor, and Interleukin-2 Receptor {gamma}-Chain Messenger Ribonucleic Acids That Are Regulated by GnRH in Vitro
J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 743 - 750.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
E. R. Norwitz, G. R. Cardona, K.-H. Jeong, and W. W. Chin
Identification and Characterization of the Gonadotropin-releasing Hormone Response Elements in the Mouse Gonadotropin-releasing Hormone Receptor Gene
J. Biol. Chem., January 8, 1999; 274(2): 867 - 880.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Vrecl, L. Anderson, A. Hanyaloglu, A. M. McGregor, A. D. Groarke, G. Milligan, P. L. Taylor, and K. A. Eidne
Agonist-Induced Endocytosis and Recycling of the Gonadotropin-Releasing Hormone Receptor: Effect of {beta}-Arrestin on Internalization Kinetics
Mol. Endocrinol., December 1, 1998; 12(12): 1818 - 1829.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
X. Lin and P. M. Conn
Transcriptional Activation of Gonadotropin-Releasing Hormone (GnRH) Receptor Gene by GnRH and Cyclic Adenosine Monophosphate
Endocrinology, September 1, 1998; 139(9): 3896 - 3902.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Kamegai, T. G. Unterman, L. A. Frohman, and R. D. Kineman
Hypothalamic/Pituitary-Axis of the Spontaneous Dwarf Rat: Autofeedback Regulation of Growth Hormone (GH) Includes Suppression of GH Releasing-Hormone Receptor Messenger Ribonucleic Acid
Endocrinology, August 1, 1998; 139(8): 3554 - 3560.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
K. K. Arora, Z. Cheng, and K. J. Catt
Mutations of the Conserved DRS Motif in the Second Intracellular Loop of the Gonadotropin-Releasing Hormone Receptor Affect Expression, Activation, and Internalization
Mol. Endocrinol., August 1, 1997; 11(9): 1203 - 1212.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
G. Aleppo, S. F. Moskal II, P. A. De Grandis, R. D. Kineman, and L. A. Frohman
Homologous Down-Regulation of Growth Hormone-Releasing Hormone Receptor Messenger Ribonucleic Acid Levels
Endocrinology, March 1, 1997; 138(3): 1058 - 1065.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
U. B. Kaiser, P. M. Conn, and W. W. Chin
Studies of Gonadotropin-Releasing Hormone (GnRH) Action Using GnRH Receptor-Expressing Pituitary Cell Lines
Endocr. Rev., February 1, 1997; 18(1): 46 - 70.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Kovacs, A. V. Schally, B. Csernus, and Z. Rekasi
Luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix down-regulates the mRNA expression of pituitary receptors for LH-RH by counteracting the stimulatory effect of endogenous LH-RH
PNAS, February 13, 2001; 98(4): 1829 - 1834.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society